CompuGroup Medical SE & Co. KGaA (ETR:COP)
22.62
-0.08 (-0.35%)
Mar 31, 2025, 1:38 PM CET
ETR:COP Revenue
In the year 2024, CompuGroup Medical SE & Co. KGaA had annual revenue of 1.19B EUR, down -3.39%. CompuGroup Medical SE & Co. KGaA had revenue of 316.72M in the quarter ending December 31, 2024, a decrease of -0.96%.
Revenue
1.19B
Revenue Growth
-3.39%
P/S Ratio
0.99
Revenue / Employee
134.58K
Employees
8,815
Market Cap
1.17B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.19B | -41.60M | -3.39% |
Dec 31, 2023 | 1.23B | 53.10M | 4.52% |
Dec 31, 2022 | 1.17B | 112.11M | 10.55% |
Dec 31, 2021 | 1.06B | 193.49M | 22.26% |
Dec 31, 2020 | 869.21M | 98.78M | 12.82% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Merck KGaA | 21.16B |
Siemens Healthineers AG | 22.67B |
Fresenius SE & Co. KGaA | 21.83B |
Bayer Aktiengesellschaft | 46.61B |
Sartorius Aktiengesellschaft | 3.38B |
Fresenius Medical Care AG | 19.34B |
Carl Zeiss Meditec AG | 2.08B |
Fielmann Group AG | 2.16B |
CompuGroup Medical SE & Co. KGaA News
- 3 days ago - EQS-PVR: CompuGroup Medical SE & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 25 days ago - CompuGroup Medical: FY 2024 Results Align, Growth Expected in 2025 - Wallstreet:Online
- 27 days ago - CompuGroup Medical Slashes 2024 Dividend to Legal Minimum! - Wallstreet:Online
- 27 days ago - EQS-Adhoc: Ad-hoc: CompuGroup Medical SE & Co. KGaA intends to reduce the annual dividend for the financial year 2024 to the legal minimum - Wallstreet:Online
- 6 weeks ago - EQS-News: Final results of voluntary public takeover offer – CVC has secured 21.85% of total share capital and voting rights of CompuGroup Medical - Wallstreet:Online
- 2 months ago - EQS-News: Successful conclusion of initial acceptance period of CVC offer for CompuGroup Medical – Additional acceptance period from 29 January to 11 February 2025 - Wallstreet:Online
- 2 months ago - EQS-News: CVC exceeds minimum acceptance threshold for voluntary public tender offer for CompuGroup Medical – additional acceptance period expected to commence on 29 January - Wallstreet:Online
- 3 months ago - EQS-News: CGM issues joint reasoned statement recommending that shareholders accept CVC's voluntary public takeover offer - Wallstreet:Online